|
Original paper
Corticosteroid-induced mood changes in systemic autoimmune diseases: a multicentric study
Mohammed Mahmoud Hamouda
1
,
Mohammed Abdel-Hassib
2
,
Omima Sayed Mohammed
4, 5
,
- Department of Psychiatry, Faculty of Medicine, Al-Azhar University, Cairo, Egypt
- Department of Internal Medicine, Faculty of Medicine, Al-Azhar University, Cairo, Egypt
- Department of Internal Medicine, College of Medicine, Shaqra University, Saudi Arabi
- Department of Medical Microbiology and Immunology, Faculty of Medicine, Ain Shams University, Cairo, Egypt
- Department of Microbiology, College of Medicine, Najran University, Saudi Arabia
- Internal Medicine Department, Faculty of Medicine, Tanta University, Tanta, Egypt
- National Liver Institute, Menoufia University, Shebin El-Kom, Egypt
- Department of Psychiatry, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt
Gastroenterology Rev
Online publish date: 2025/12/07
Get citation
PlumX metrics:
1. Gensler LS. Glucocorticoids: complications to anticipate and prevent. Neurohospitalist 2013; 3: 92-7. 2.
Brown ES. Effects of glucocorticoids on mood, memory, and the hippocampus. Treatment and preventive therapy. Ann N Y Acad Sci 2009; 1179: 41-55. 3.
Murray CJL, Richards MA, Newton JN, et al. UK health performance: findings of the Global Burden of Disease Study 2010. Lancet 2013; 381: 997-1020. 4.
World Health Organization. The Global Burden of Disease: 2004 update (WHO Press, Geneva, Switzerland, 2008). 5.
Jones PB. Adult mental health disorders and their age at onset. Br J Psychiatry Suppl 2013; 54: s5-10. 6.
Rohde P, Lewinsohn PM, Klein DN, et al. Key characteristics of major depressive disorder occurring in childhood, adolescence, emerging adulthood, adulthood. Clin Psychol Sci 2013; 1: 41-53. 7.
Dunn V, Goodyer IM. Longitudinal investigation into childhood-and adolescence-onset depression: psychiatric outcome in early adulthood. Br J Psychiatry 2006; 188: 216-22. 8.
Angold A, Costello EJ, Worthman CM. Puberty and depression: the roles of age, pubertal status and pubertal timing. Psychol Med 1998; 28: 51-61. 9.
Hankin BL, Abramson LY, Moffitt TE, et al. Development of depression from preadolescence to young adulthood: emerging gender differences in a 10-year longitudinal study. J Abnorm Psychol 1998; 107: 128-40. 10.
Brown ES, Suppes T. Mood symptoms during corticosteroid therapy: a review. Harv Rev Psychiatry 1998: 5: 239-46. 11.
Bakeer MS, Youssef MI, Elshazly HM, et al. On-treatment improvement of an emerging psychosomatic depressive disorder among salmonella carriers: a multicenter experience from Egypt. Infect Drug Resist 2019; 12: 2573-82. 12.
Kershner P, Wang Cheng R. Psychiatric side effects of steroid therapy. Psychosomatics 1989; 30: 135-9. 13.
Gerner RH, Wilkins JN. CSF Cortisol in patients with depression, mania, or anorexia nervosa and in normal subjects. Am J Psychiatry1983; 140: 92-4. 14.
Reckart MD, Eisendrath SJ. Exogenous corticosteroid effects on mood and cognition: case presentations. Int J Psychosom 1990; 37: 57-61. 15.
Bolanos SH, Khan DA, Hanczyc M, et al. Assessment of mood states in patients receiving long-term corticosteroid therapy and in controls with patient-rated and clinician-rated scales. Ann Allergy Asthma Immunol 2004; 92: 500-5.
Copyright: © 2025 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License ( http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
|
